MedPath

Cross-Sectional Survey on the Use of Tobacco Products - Italy

Terminated
Conditions
Tobacco Use
Registration Number
NCT03527004
Lead Sponsor
Philip Morris Products S.A.
Brief Summary

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Italy.

Detailed Description

The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Italy and in adult IQOS users registered in the IQOS user database of Philip Morris Italia S.r.l. (Italy IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are:

1. Estimate the prevalence of current tobacco use status in the study population.

2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse).

3. Explore the association between self-reported health status and use of tobacco products in the study population.

4. Explore the association between patterns of use (including misuse) with motivation to use, perceived quality attributes of IQOS (e.g. risk and self-reported changes since switching to the product, in a number of relevant domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in Italy registered in the Italy IQOS User Database.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
6107
Inclusion Criteria

Not provided

Exclusion Criteria
  • Not meeting the inclusion criteria.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of current tobacco useStudy duration (3 years).

Prevalence of current tobacco use status in the study population.

Past tobacco use statusStudy duration (3 years).

Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.

IQOS use experienceStudy duration (3 years).

Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of relevant domains where IQOS may have potential benefits).

Self-reported health statusStudy duration (3 years).

Association between self-reported health status and use of tobacco products in the study population.

Perceived riskStudy duration (3 years).

Association between patterns of use with perceived risk.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Philip Morris Products S.A.

🇨🇭

Lausanne, Switzerland

Philip Morris Products S.A.
🇨🇭Lausanne, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.